SPL 1.09% 9.3¢ starpharma holdings limited

Ann: DEP irinotecan clinical data presented at AACR meeting, page-16

  1. 15,538 Posts.
    lightbulb Created with Sketch. 5604
    Not even half way through the trading day and over 550,000 shares dumped already (again at record lows) would suggest some just aren't convinced about the 4 separate DEP® irinotecan ASX announcements released by JF & Co. in the last 34 days ... I guess it is either that or perhaps the past performance of this mob - take your pick I guess ?


    @sarge17 - yes I also found those comments about 'not wanting a DEP® deal at these low share prices' laughable ... you know the very licensing deal(s) LT shareholders have been waiting years for Starpharma to secure ?


    upload_2023-10-17_12-32-4.png
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.3¢
Change
0.001(1.09%)
Mkt cap ! $38.35M
Open High Low Value Volume
9.3¢ 9.4¢ 9.3¢ $6.681K 71.79K

Buyers (Bids)

No. Vol. Price($)
1 6198 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.4¢ 5 1
View Market Depth
Last trade - 14.00pm 19/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.